Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?
about
Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritisThe effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosusMycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse ModelAccelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation.Risk factors in cardiovascular disease in systemic lupus erythematosus.Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?Mycophenolate mofetil and atherosclerosis: results of animal and human studies.Lupus: improving long-term prognosis.Enhancement of Mycophenolate Mofetil Permeation for Topical Use by Eucalyptol and N-Methyl-2-pyrrolidone.A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation.Conversion to combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy for renal dysfunction in liver transplant patients: never too late?Mycophenolate mofetil as an immunomodulatory silver bullet in atherogenesis?Implications of immunosuppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients
P2860
Q21195423-9FEE564A-14DD-4B24-94AA-ED7A5A2FCBC6Q28486062-F3BF8A50-BC76-4E7D-8BE0-69A673936E19Q30386671-0C569BFA-BBFE-42C7-B68C-0F2D9FF68980Q34170097-3499DCA4-B1B7-4E8C-88B4-936C8F5588D5Q36043804-0F98A662-5A11-4326-A0F6-44732D7649A0Q36644837-301578FA-4C1C-4796-9B34-104BDAE75C7EQ36752124-5197EB7F-65D4-4DE2-905D-6556BA1EC757Q36958317-801A44B4-F381-41BB-9B81-8AE0EEE03D27Q37121353-AFE87BB8-CB18-430F-82F7-965183067444Q39653720-FDF2D047-C958-4845-AE8F-3D1DCB3D3182Q42109762-529C30B0-51E8-49E5-A03E-1D4FB842B7BCQ42554622-397B9E64-BD89-489E-93FF-725DE2853FC4Q57839864-B9E46980-BAE3-4547-9F36-E6221A958EEFQ58482114-465ED864-23DC-4912-969F-B98B707F85EA
P2860
Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?
@ast
Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?
@en
type
label
Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?
@ast
Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?
@en
prefLabel
Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?
@ast
Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?
@en
P2093
P1476
Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?
@en
P2093
Anthony C Allison
Erik S G Stroes
John J P Kastelein
Michael R Hayden
Sander I van Leuven
P304
P356
10.1016/J.CARDIORES.2005.09.018
P577
2005-11-10T00:00:00Z